These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9123157)
1. Does early steroid withdrawal influence rejection and infection episodes during the first 2 years after heart transplantation? Seydoux C; Berguer DG; Stumpe F; Hurni M; Ruchat P; Fischer A; Müller X; Sadeghi H; Goy JJ Transplant Proc; 1997; 29(1-2):620-4. PubMed ID: 9123157 [No Abstract] [Full Text] [Related]
2. Effects of cyclosporine A monotherapy on the incidence of rejection and infection episodes in heart transplant patients. Seydoux C; Stumpe F; Hurni M; Ruchat P; Fischer A; Mueller X; von Segesser L; Goy JJ Transplant Proc; 1998 Dec; 30(8):4037-43. PubMed ID: 9865288 [No Abstract] [Full Text] [Related]
3. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation. Maccherini M; Bernazzali S; Diciolla F; Giunti G; Bizzarri F; Lisi GF; Davoli G; Biagioli B; Giomarelli PP; Simeone F; Caciorgna M; Marchetti L; Pula G; Sani G; Toscano M Transplant Proc; 1998 Aug; 30(5):1904-5. PubMed ID: 9723327 [No Abstract] [Full Text] [Related]
4. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone. Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543 [No Abstract] [Full Text] [Related]
5. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Schulak J; May E; Post A; Fasola C; Mulligan D; Sterling R Transplant Proc; 1997; 29(1-2):555-6. PubMed ID: 9123126 [No Abstract] [Full Text] [Related]
6. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation. Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219 [No Abstract] [Full Text] [Related]
7. Study of early corticosteroid withdrawal in cardiac transplantation. Delgado D; Arazi HC; Sellanes M; Cáceres M; Cárdenas C; Morales C; Bortman G; Nojek C Transplant Proc; 1999 Sep; 31(6):2524-5. PubMed ID: 10500699 [No Abstract] [Full Text] [Related]
8. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461 [TBL] [Abstract][Full Text] [Related]
9. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation. Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332 [No Abstract] [Full Text] [Related]
10. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection. Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215 [No Abstract] [Full Text] [Related]
11. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients. Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465 [No Abstract] [Full Text] [Related]
13. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral. Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346 [No Abstract] [Full Text] [Related]
14. Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine. Roodnat JI; Zietse R; Rischen-Vos J; van Gelder T; IJzermans JN; Weimar W Transplant Proc; 1998 Jun; 30(4):1199-200. PubMed ID: 9636486 [No Abstract] [Full Text] [Related]
15. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]
16. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A. Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333 [No Abstract] [Full Text] [Related]
17. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481 [No Abstract] [Full Text] [Related]